
Garden Stage Ltd
83
Recent developments include a Nasdaq compliance issue and resolution, a registered direct offering, and a reverse share split.
- Garden Stage Limited received a delinquency notification from Nasdaq regarding minimum bid price compliance in December 2024 [N3].
- The company regained compliance with Nasdaq minimum bid price requirements in June 2025 [N2].
- In July 2025, Garden Stage Limited announced a $4.2 million registered direct offering of ordinary shares [N1].
- The company effected a 200-for-1 reverse share split of its ordinary shares on March 6, 2026 [S1].
Garden Stage Ltd operates primarily in Hong Kong through its wholly owned subsidiaries, providing a diversified range of financial services including advisory, due diligence, introducing and referral, investment management, securities brokerage, underwriting, and placement services. Its subsidiaries hold the necessary licenses under the Hong Kong Securities and Futures Ordinance to conduct regulated activities. The company’s business model leverages synergies across its service lines to generate diversified revenue streams. It has recently expanded into the production and sale of robots through acquisitions and establishing a wholly foreign owned enterprise in China. The company’s revenues have grown from $1.41 million in 2024 to $7.28 million in 2026, though it has reported net losses over the same period. It maintains regulatory capital compliance and has invested in upgrading its technology infrastructure to support its operations and customer service.
Garden Stage Ltd is a Hong Kong-based financial services company operating through licensed subsidiaries offering advisory, brokerage, asset management, underwriting, and related services. The company reported revenues of $7.28 million and a net loss of $13.84 million for the fiscal year ended March 31, 2026. It maintains regulatory capital compliance and has a current ratio of 1.72 as of the same date. Recent developments include a reverse share split, capital raising via a $4.2 million registered direct offering, and regaining Nasdaq minimum bid price compliance. The company has expanded into robot production through acquisitions and a new enterprise in China, with production commencing in April 2026. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
Garden Stage Ltd has demonstrated revenue growth over recent years, expanding its service offerings and client base. The company’s diversified business lines and regulatory licenses provide a platform for integrated financial services and cross-selling opportunities. Its recent capital raising activities and Nasdaq compliance restoration support its financial flexibility and market presence. The acquisition of Mental Form (BVI) Limited and establishment of a wholly foreign owned enterprise in China to support robot production represent strategic diversification beyond financial services. Investments in technology infrastructure aim to enhance operational efficiency and customer experience, potentially strengthening competitive positioning.
The company has reported significant net losses despite revenue growth, indicating challenges in achieving profitability. Its business is subject to regulatory risks, including compliance with capital adequacy and licensing requirements in Hong Kong, which could impact operations if not met. The financial services market in Hong Kong is highly competitive, with pressure on fees and market share. The success of diversification into robot production is uncertain, with production only commencing recently. Concentration of revenues among a few major customers poses risks to revenue stability. Additionally, the company’s financial position and cash flows could be affected by adverse market conditions or operational setbacks.
Garden Stage Ltd’s moat is based on its diversified financial services portfolio and regulatory licenses in Hong Kong, which provide barriers to entry. Its subsidiaries’ licenses for securities dealing, advising, and asset management under the Hong Kong SFO enable it to offer integrated financial services. The company’s ability to cross-sell among its advisory, brokerage, asset management, and underwriting services creates potential synergies and customer loyalty. Its participation in the SEHK and HKSCC with a trading right further supports its brokerage and underwriting activities. However, the company operates in a highly competitive and fragmented financial services market in Hong Kong, facing competition from larger and more established firms as well as smaller providers. The moat is thus moderate, relying on regulatory compliance, service integration, and client relationships.
• Regulatory Compliance Risk: Failure to meet capital adequacy or licensing requirements under Hong Kong regulations could result in penalties, suspension, or revocation of licenses, materially affecting operations.
• Market and Competitive Risk: Intense competition in Hong Kong’s financial services industry may pressure fees and market share, impacting profitability and growth.
• Customer Concentration Risk: A significant portion of revenues is derived from a few major customers, creating dependency and potential volatility in revenue streams.
• Operational and Execution Risk: The company’s diversification into robot production is nascent, with uncertainties around successful integration and market acceptance.
• Financial Performance Risk: Sustained net losses and cash flow usage highlight challenges in achieving profitability and financial sustainability.
Business trends: Revenue growth driven by diversified financial services and expansion into robot production; increased technology infrastructure investment.
Execution milestones: Completion of reverse share split, Nasdaq compliance regained, capital raised via direct offering, and commencement of robot production.
Key risks: Regulatory compliance challenges, competitive market pressures, customer concentration, operational risks in new business lines, and ongoing net losses.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Garden Stage Ltd is a Hong Kong-based financial services provider operating through wholly owned subsidiaries.
- Its services include advisory, due diligence, introducing and referral, investment management, securities brokerage, underwriting, and placement.
- Subsidiaries include I Win Holding Limited (consultancy), I Win Securities Limited (licensed for Type 1 dealing in securities), I Win Asset Management Limited (licensed for Type 4 advising and Type 9 asset management), and I Win Consulting Limited (consultancy).
- I Win Securities Limited holds a trading right with the SEHK and is a participant of SEHK and HKSCC.
- The company reported revenues of approximately $7.28 million, $5.47 million, and $1.41 million for fiscal years ending March 31, 2026, 2025, and 2024, respectively.
- Net losses were $13.84 million, $4.32 million, and $4.59 million for the same periods.
- Earnings per share (basic and diluted) were reported as $1.38 for the year ended March 31, 2026.
- The company completed a 200-for-1 reverse share split on March 6, 2026.
- Garden Stage Ltd established a wholly foreign owned enterprise in China and acquired Mental Form (BVI) Limited and its subsidiary in 2026 to support planned production and sales of robots, with production starting in April 2026.
- The company’s revenues are diversified across advisory fees, brokerage commissions, handling income, introducing and referral income, investment management fees, underwriting and placement income, and interest income.
- The company’s liquidity as of March 31, 2026, shows current assets of approximately $30.5 million and current liabilities of approximately $17.7 million, yielding a current ratio of 1.72.
- Cash and restricted cash totaled approximately $17.5 million as of March 31, 2026, held in HKD, USD, and JPY.
- Operating subsidiaries comply with regulatory capital requirements set by the Hong Kong Securities and Futures Commission (HKSFC).
- The company’s business is subject to regulatory oversight and licensing requirements in Hong Kong.
- Major customers accounted for significant portions of revenue, with two counterparties representing 32% and 12% of total revenue in fiscal 2026.
- The company has been active in capital raising, including a $4.2 million registered direct offering announced in July 2025.
- Garden Stage Limited regained compliance with Nasdaq minimum bid price requirements in June 2025 after receiving a delinquency notification in December 2024.
- The company’s technology infrastructure has been upgraded to support its financial services offerings, including portfolio management, risk management, and customer relationship management systems.
- The company’s financial results and operations are influenced by market conditions, regulatory changes, competition, and geopolitical events, with disclosures noting no material impact from recent global conflicts as of the report date.
Generated 2026-07-31
- S1 | 2026-07-31 | 20-F
- S2 | 2026-06-15 | 6-K
- N1 | 2025-07-24 | www.nasdaq.com | Garden Stage Limited Announces $4.2 Million Registered Direct Offering of Ordinary Shares | https://www.nasdaq.com/articles/garden-stage-limited-announces-42-million-registered-direct-offering-ordinary-shares
- N2 | 2025-06-24 | www.nasdaq.com | Garden Stage Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement | https://www.nasdaq.com/articles/garden-stage-limited-regains-compliance-nasdaq-minimum-bid-price-requirement
- N3 | 2024-12-30 | www.nasdaq.com | Garden Stage Limited Receives Delinquency Notification from Nasdaq Regarding Minimum Bid Price Compliance | https://www.nasdaq.com/articles/garden-stage-limited-receives-delinquency-notification-nasdaq-regarding-minimum-bid-price
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


